Status:
COMPLETED
Beetroot Supplementation in Women Enjoying Exercise Together
Lead Sponsor:
Indiana University
Collaborating Sponsors:
IU Health University Hospital
Indiana CTSI Clinical Research Center
Conditions:
Aging
Postmenopause
Eligibility:
FEMALE
18-75 years
Phase:
NA
Brief Summary
This study seeks to determine the feasibility of an exercise training progression with the consumption of beetroot juice prior to exercise in postmenopausal women. Results from this investigation will...
Detailed Description
An increasing body of evidence has supported acute benefits of beetroot juice including lowered blood pressure and greater muscle oxygenation during exercise. Thus, consumption of beetroot juice prior...
Eligibility Criteria
Inclusion
- Post-menopausal women (self-report)
- Between the ages of 18-75 years (confirmed by birth date listed on participant's driver license at screening visit)
- Physician's clearance for study participation (required prior to baseline testing)
- English-speaking
- Body mass index between 25.0 to 39.9 kg/m\^2 (measured on-site at screening visit)
- Able to ambulate without assistance
Exclusion
- Unable to provide informed consent
- 18-75 of age (confirmed by birth date listed on participant's driver license at screening visit)
- Body mass index \< 25.0 or \>39.9 kg/m\^2 (measured on-site at screening visit)
- Greater than stage II hypertension (i.e. \>159/99 mm Hg)
- Current smoker (self-report)
- Currently pregnant, lactating, or trying to become pregnant (self-report)
- Habitually exercise training \>= 3 times per week (self-report)
- Significant orthopedic limitations or other contraindications to strenuous exercise
- Live or work \>50 miles from Bloomington study site or do not have transportation to the study site
- Anticipate elective surgery during the study period
- Plan to move residence or travel out of the local area during the study period
- History of major metabolic disease (e.g. Type I diabetes, Type II diabetes, thyroid disorders)
- Current use of anti-coagulants (e.g. Coumadin or Warfarin)
- Current use of prescription medications that affect heart rate or blood vessel dilation (e.g. phosphodiesterase-5 inhibitors, proton pump inhibitors, systemic adrenergic blockers, nitrates, calcium channel blockers, hormone replacement therapy) (self-report and confirmed on-site at screening visit)
- Psychological or social characteristic that would interfere with their ability to fully participate in the study (i.e. taking longer than allowed time to complete cognitive assessments)
Key Trial Info
Start Date :
January 30 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 26 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04370756
Start Date
January 30 2020
End Date
May 26 2023
Last Update
February 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Indiana University
Bloomington, Indiana, United States, 47401